Balakrishna Haridas

Professor of Practice, Biomedical Engineering

Director, National Center for Therapeutics Manufacturing (NCTM)

Site Director, Advanced Regenerative Manufacturing Institute (ARMI)

Executive Director, TEES Division of Commercialization and Entrepreneurship

Affiliated Faculty, Center for Remote Health Technologies and Systems

Haridas

Office: 5014 ETB
Phone: 979.845.3348
Email: bharidas@tamu.edu

Research Interests

Dr. Balakrishna Haridas is professor of practice in the Department of Biomedical Engineering, Director of the National Center for Therapeutics Manufacturing, and Executive Director of the TEES Division of Entrepreneurship & Commercialization.  Dr. Haridas is also the Texas site director for the Advanced Regenerative Manufacturing Institute (ARMI) www.armiusa.org.  ARMI's mission is make practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones.  To that end, the technical scope for ARMI work includes innovations across five thrust areas: (1) Cell Selection, Culture and Scale-up, (2) Biomaterial Selection and Scale-up; (3) Tissue Process Automation and Monitoring; (4) Tissue Maturing Technologies and (5) Tissue Preservation and Transport.

He is a serial product development entrepreneur and academician with over 26 years of experience in development of products for minimally invasive laparoscopic and endovascular surgery, wound healing and soft tissue repair and regeneration. Prior to joining Texas A&M, Dr. Haridas was director of the Medical Device Innovation & Entrepreneurship Program, the Master of Engineering program, and associate professor of biomedical engineering at the University of Cincinnati. Dr. Haridas' career prior to these appointments includes the following: president and founder of Device & Implant Innovations LLC; chief technology officer of Biomerix Corporation; founder and director of the NSF/IUCRC Minimally Invasive Medical Technologies Center (MIMTeC); and principal/partner and director at Stress Engineering Services Inc.

During his career, Dr. Haridas has raised and directed more than $80 Million in funding for product R&D and commercialization from industry, government (NSF/NIH) and venture capital sources. He is a member of multiple societies, has served as editor and reviewer for many journals and won several academic awards at the University of Cincinnati. He also is a juror for the prestigious Medical Design Excellence Awards, holds several patents, has published a number of peer-reviewed articles and given dozens of conference and keynote presentations.

Projects in Dr. Haridas’ lab include a collaboration with Cincinnati Children’s Hospital aimed at developing a viable replacement for neonatal/pediatric trachea as a treatment for congenital tracheal stenosis. This same technology also is being engineered to serve as a tracheal repair/replacement implant for adult patients who have airway injury as a result of blunt or penetrating trauma or cancer. Dr. Haridas’ lab also serves as a product realization space with capabilities that include additive manufacturing, injection molding, laser machining, ultrasonic spray coating systems, polymer extrusion and device functional testing to support a multitude of device development projects. 

Education

  • Ph.D., Biomedical Engineering, University of Cincinnati
  • M.S., Engineering Mechanics, University of Alabama
  • B.E., Civil Engineering, Bangalore University, India